Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit
Nonsteroidal anti-inflammatory drugs (NSAIDs) 1–5 containing an N-acyl hydrazone subunit were prepared and their antiplatelet and antithrombotic activities assessed in vitro and in vivo. Compounds 1–5 inhibited the platelet aggregation induced by adenosine diphosphate and/or arachidonic acid, with i...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/2/2089 |
id |
doaj-e94f9980cf8b4224ad5a42ffb4507e84 |
---|---|
record_format |
Article |
spelling |
doaj-e94f9980cf8b4224ad5a42ffb4507e842020-11-24T22:12:47ZengMDPI AGMolecules1420-30492014-02-011922089209910.3390/molecules19022089molecules19022089Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone SubunitRafael Consolin Chelucci0Luiz Antônio Dutra1Maria Elisa Lopes Pires2Thais Regina Ferreira de Melo3Priscila Longhin Bosquesi4Man Chin Chung5Jean Leandro dos Santos6Departamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilDepartamento de Fármacos e Medicamentos, Faculdade de Ciências Farmacêuticas–UNESP, Rodovia Araraquara Jaú Km, Araraquara, SP, 01, 14801-902, BrazilNonsteroidal anti-inflammatory drugs (NSAIDs) 1–5 containing an N-acyl hydrazone subunit were prepared and their antiplatelet and antithrombotic activities assessed in vitro and in vivo. Compounds 1–5 inhibited the platelet aggregation induced by adenosine diphosphate and/or arachidonic acid, with inhibition rates of 18.0%–61.1% and 65.9%–87.3%, respectively. Compounds 1 and 5 were the most active compounds, inhibiting adenosine-diphosphate-induced platelet aggregation by 57.2% and 61.1%, respectively. The inhibitory rates for arachidonic-acid-induced platelet aggregation were similar for compound 2 (80.8%) and acetylsalicylic acid (ASA, 80%). After their oral administration to mice, compounds 1, 3, and 5 showed shorter mean bleeding times than ASA. Compounds 1 and 5 also protected against thromboembolic events, with survival rates of 40% and 33%, respectively, compared with 30% for ASA. In conclusion, these results indicate that these novel NSAIDs containing an NAH subunit may offer better antiplatelet and antithrombotic activities than ASA.http://www.mdpi.com/1420-3049/19/2/2089hydrazoneantiplateletantithromboticNSAIDsbleeding time |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rafael Consolin Chelucci Luiz Antônio Dutra Maria Elisa Lopes Pires Thais Regina Ferreira de Melo Priscila Longhin Bosquesi Man Chin Chung Jean Leandro dos Santos |
spellingShingle |
Rafael Consolin Chelucci Luiz Antônio Dutra Maria Elisa Lopes Pires Thais Regina Ferreira de Melo Priscila Longhin Bosquesi Man Chin Chung Jean Leandro dos Santos Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit Molecules hydrazone antiplatelet antithrombotic NSAIDs bleeding time |
author_facet |
Rafael Consolin Chelucci Luiz Antônio Dutra Maria Elisa Lopes Pires Thais Regina Ferreira de Melo Priscila Longhin Bosquesi Man Chin Chung Jean Leandro dos Santos |
author_sort |
Rafael Consolin Chelucci |
title |
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit |
title_short |
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit |
title_full |
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit |
title_fullStr |
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit |
title_full_unstemmed |
Antiplatelet and Antithrombotic Activities of Non-Steroidal Anti-Inflammatory Drugs Containing an N-Acyl Hydrazone Subunit |
title_sort |
antiplatelet and antithrombotic activities of non-steroidal anti-inflammatory drugs containing an n-acyl hydrazone subunit |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2014-02-01 |
description |
Nonsteroidal anti-inflammatory drugs (NSAIDs) 1–5 containing an N-acyl hydrazone subunit were prepared and their antiplatelet and antithrombotic activities assessed in vitro and in vivo. Compounds 1–5 inhibited the platelet aggregation induced by adenosine diphosphate and/or arachidonic acid, with inhibition rates of 18.0%–61.1% and 65.9%–87.3%, respectively. Compounds 1 and 5 were the most active compounds, inhibiting adenosine-diphosphate-induced platelet aggregation by 57.2% and 61.1%, respectively. The inhibitory rates for arachidonic-acid-induced platelet aggregation were similar for compound 2 (80.8%) and acetylsalicylic acid (ASA, 80%). After their oral administration to mice, compounds 1, 3, and 5 showed shorter mean bleeding times than ASA. Compounds 1 and 5 also protected against thromboembolic events, with survival rates of 40% and 33%, respectively, compared with 30% for ASA. In conclusion, these results indicate that these novel NSAIDs containing an NAH subunit may offer better antiplatelet and antithrombotic activities than ASA. |
topic |
hydrazone antiplatelet antithrombotic NSAIDs bleeding time |
url |
http://www.mdpi.com/1420-3049/19/2/2089 |
work_keys_str_mv |
AT rafaelconsolinchelucci antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT luizantoniodutra antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT mariaelisalopespires antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT thaisreginaferreirademelo antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT priscilalonghinbosquesi antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT manchinchung antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit AT jeanleandrodossantos antiplateletandantithromboticactivitiesofnonsteroidalantiinflammatorydrugscontainingannacylhydrazonesubunit |
_version_ |
1725802450293620736 |